MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm
Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.

TZ. Ren, K. Nie, LJ. Wang (Guangzhou, China)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Health associated quality of life (HAQL) and humor/cognitive complaints predict mortality in Parkinson’s disease (PD)

P. Bugalho, R. Barbosa, F. Ladeira, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisbon, Portugal)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease

C. Terroba-Chambi, D. Vigo, M. Merello (Caba, Argentina)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Hemispheric Differences in Motor Circuitry of Parkinson’s disease: Metabolism and Micro-Structure

DAN. Stein, N. Goldberg, L. Domachevsky, H. Bernstine, M. Nidam, D. Groshar, M. Lorberboym, S. Israeli-Korn, M. Gomori, Y. Assaf, S. Hassin-Baer (Tel-Aviv, Israel)

Neuroimaging  ·  Les Muses Terrace, Level 3

Monday, September 23, 2019

1:45pm-3:15pm
High Content Screening of synucleinopathy in primary cortical neurons : dissecting out the interplay between the basic synuclein pools

F. de Giorgi, E. Bezard, F. Ichas (Bordeaux, France)

Other  ·  Agora 2 West, Level 2

Wednesday, September 25, 2019

1:15pm-2:45pm
Higher levels of physical activity is associated with fewer non-motor symptoms in early Parkinson’s disease: a 1-year follow-up study

S. Ng, N. Chia, M. Abbas, KY. Tay, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Higher probability of prodromal Parkinson’s disease is related to lower performance in all cognitive domains

A. Bougea, M. Maraki, M. Yannakoulia, M. Stamelou, G. Xiromerisiou, M. Kosmidis, E. Dardiotis, G. Hadjigeorgiou, P. Sakka, C. Anastasiou, L. Stefanis, N. Scarmeas (Athens, Greece)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
How Commonly Does Parkinson’s Disease Present with Dystonia?

P. Popa, C. Brown, C. Henchcliffe, H. Sarva (New York, NY, USA)

Phenomenology and Clinical Assessment of Movement Disorders  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
How Parkinson’s Disease Affects Value-Based Decisions

L. Montaser-Kouhsari, R. Gerraty, A. Bakkour, D. Shohamy (New York, NY, USA)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
How reliable are non-blinded evaluations of motor UPDRS? a comparison of blinded vs. un-blinded UPDRS scores in 14 patients with advanced Parkinson´s disease

G-M. Hariz, A. Fredricks, R. Stenmark, J. Linder, M. Hariz, L. Forsgren, P. Blomstedt (Umea, Sweden)

Surgical Therapy  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 67
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley